Showing results (1871-1880 of 2,034) with videos related to

Sort By:
Pageof 204
Endocrine-Related Cancer|April 13, 2011
Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal womenChristine M Friedenreich, Heather K Neilson, Christy G Woolcott, et al.
Health and Social Care Delivery Research|April 5, 2025
Multiple Symptoms Study 3 - An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled TrialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2025
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian CancerMirat Shah, Ting-Yu Chen, Gwynn Ison, et al.
Cell Reports|February 5, 2013
In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesisSara Zanivan, Alexander Meves, Kristina Behrendt, et al.
Nucleic Acids Research|February 27, 2026
CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAsArindam Chaudhury, Natee Kongchan, Shebna A Massey, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Fully T2T pedigree assemblies reveal genetic stability and epigenetic plasticity of human centromeres across inheritance and cell-fate transitionsShihua Dong, Xiaoyun Xing, Monika Cechova, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 12, 2021
A Novel Variant of ATP5MC3 Associated with Both Dystonia and Spastic ParaplegiaDerek E Neilson, Michael Zech, Robert B Hufnagel, et al.
Hypertension (Dallas, Tex. : 1979)|May 10, 2021
Gut Microbiome-Derived Metabolite Trimethylamine N-Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and HumansVienna E Brunt, Abigail G Casso, Rachel A Gioscia-Ryan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2006
The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216E E Codd, J R Carson, R W Colburn, et al.
Pageof 204